Many patients with hematological malignancies, such as acute myeloid leukemia, receive an
allogeneic hematopoietic cell transplantation (HCT) to cure their underlying condition …

Disruptions to the gut microbiota have been associated with adverse outcomes including
graft-versus-host disease, infections, and mortality after hematopoietic cell transplantation …

Abstract Changes in the gut microbiome have pivotal roles in the pathogenesis of acute graft-
versus-host disease (aGVHD) after allogenic haematopoietic cell transplantation (allo …

Fecal microbiota transplantation in patients with acute and chronic graft-versus-host disease-spectrum
of responses and safety profile. Results from a prospective, multicenter study Fecal microbiota …

Antimicrobial resistance (AMR) is a rising and significant threat to global health [1]. In
addition to the considerable economic burden, AMR is associated with increased morbidity …

Introduction: Treatment-refractory, acute graft-versus-host disease (GvHD) of the lower
gastrointestinal tract (GI) after allogeneic hematopoietic stem cell transplantation is life …

The human microbiota heavily influences most vital aspects of human physiology including
organ transplantation outcomes and transplant rejection risk. A variety of organ …

The disruption of gut microbiota eubiosis has been linked to major complications in
allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Various strategies …

Blastocystis hominis is the most common intestinal parasite found in humans and many
other hosts. Pathogenicity of Blastocystis spp. remains controversial, and it has been …

The incidence of cancer has shown a great increase during the past decades and poses
tough challenges to cancer treatment. Anti-tumour immunotherapy, represented by immune …